Biobizkaia
Forschungszentrum
Massachusetts Institute of Technology
Cambridge, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Massachusetts Institute of Technology (11)
2023
-
Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes
Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 927-936
2022
-
PIGN encephalopathy: Characterizing the epileptology
Epilepsia, Vol. 63, Núm. 4, pp. 974-991
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
2016
2015
-
Cardiocirculatory manifestations in Parkinson's disease patients without orthostatic hypotension
Journal of Human Hypertension, Vol. 29, Núm. 10, pp. 604-609
-
Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers
Nature Genetics, Vol. 47, Núm. 4, pp. 381-386
2012
-
HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
Nature Neuroscience, Vol. 15, Núm. 9, pp. 1245-1254
-
Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function
Journal of Biological Chemistry, Vol. 287, Núm. 53, pp. 44301-44319
2008
-
Refining genetic associations in multiple sclerosis
The Lancet Neurology